--- title: FidoCure blog | FidoCure (2) description: Read the latest in veterinary oncology research and FidoCure® scientific and clinical updates. (2) --- [![FidoCure](https://blog.fidocure.com/hs-fs/hubfs/fidocure_logo.png?width=296&height=68&name=fidocure_logo.png "FidoCure")](https://www.fidocure.com/) - [Veterinarians](https://fidocure.com/for-veterinarians/) - [Portal Login](https://dvm.fidocure.com/) - [Veterinary Blog](https://blog.fidocure.com/fidocure-blog/tag/vet) - [Case Studies](https://blog.fidocure.com/fidocure-blog/tag/case-studies) - [Webinars](https://blog.fidocure.com/fidocure-blog/tag/webinars) - [Pet Parents](https://fidocure.com/pet-parents/) - [About Us](https://fidocure.com/about-us/) - [How it works](https://fidocure.com/how-it-works/) - [Find a Clinic](https://fidocure.com/find-a-clinic/) - [Contact Us](https://fidocure.com/contact-us/) # FidoCure Veterinary Team Blog ### Read the latest in veterinary oncology research and FidoCure scientific and clinical updates from our team of experts and advisors Select Category Case Studies Press Vet Webinars This is a search field with an auto-suggest feature attached. - There are no suggestions because the search field is empty. Posts by: ## FidoCure ![](https://blog.fidocure.com/hubfs/petonc.png) ### [The Future of Pet Oncology: How AI-Driven Targeted Therapies are Revolutionizing Cancer Treatment for Dogs](https://blog.fidocure.com/fidocure-blog/the-future-of-pet-oncology-how-ai-driven-targeted-therapies-are-revolutionizing-cancer-treatment-for-dogs) The global veterinary oncology market has been experiencing remarkable growth, reaching a valuation of [$259.4B](https://www.skyquestt.com/report/veterinary-oncology-market) in 2023. This surge reflects a significant shift in how pet parents approach cancer treatment for their beloved companions. Several factors are driving this expansion: increasing pet ownership rates (accelerated by the [COVID-19 pandemic](https://www.usatoday.com/story/money/2020/09/02/dog-adoption-covid-19-creates-a-thriving-business-for-dogs/5680569002/)), a cultural shift in viewing pets as family members, and advancements in veterinary medicine. As households increasingly view their [pets as family members](https://www.economist.com/business/2024/09/12/people-are-splurging-like-never-before-on-their-pets), they're more willing to invest in sophisticated health treatments, including cancer care. This growing market presents both challenges and opportunities for innovative approaches to pet cancer treatment. [Read More](https://blog.fidocure.com/fidocure-blog/the-future-of-pet-oncology-how-ai-driven-targeted-therapies-are-revolutionizing-cancer-treatment-for-dogs) ![](https://blog.fidocure.com/hubfs/Blog_Gastrointestinal%20Cancers.png) ### [What are Gastrointestinal Cancers?](https://blog.fidocure.com/fidocure-blog/what-are-gastrointestinal-cancers) Gastrointestinal (GI) tumors in dogs are relatively rare but can be serious when they occur. These tumors affect the stomach, intestines, or other parts of the digestive system, and they can include various types such as gastrointestinal carcinomas, gastrointestinal stromal tumors (GIST), and leiomyosarcoma. While these tumors may cause symptoms like vomiting, weight loss, or changes in appetite, their treatment and prognosis depend on the type and stage of the tumor. [Read More](https://blog.fidocure.com/fidocure-blog/what-are-gastrointestinal-cancers) ![](https://blog.fidocure.com/hubfs/Cancer%20Type%20Blog%20Sized%20%20(2).png) ### [FidoCure To Unveil Breakthrough in Canine Hemangiosarcoma at 2024 Veterinary Cancer Society Annual Conference](https://blog.fidocure.com/fidocure-blog/fidocure-to-unveil-breakthrough-in-canine-hemangiosarcoma-at-2024-veterinary-cancer-society-annual-conference) **PALO ALTO, Calif. (October 15, 2024)** — FidoCure, a leader in AI-driven precision oncology for dogs, is excited to share landmark findings at the 2024 Veterinary Cancer Society (VCS) Annual Conference. This research, *Genetic Alterations Associated with Prognosis and Better Therapeutic Outcomes in Dogs with * *Splenic Hemangiosarcoma*, marks a significant advancement in the fight against hemangiosarcoma, the most prevalent and deadly cancer in dogs. This presentation highlights FidoCure’s work to connect cutting-edge science with one of the most pressing unmet needs in animal health.  [Read More](https://blog.fidocure.com/fidocure-blog/fidocure-to-unveil-breakthrough-in-canine-hemangiosarcoma-at-2024-veterinary-cancer-society-annual-conference) ![](https://blog.fidocure.com/hubfs/Blog_PancreaticCancer.png) ### [Pancreatic Cancer in Dogs](https://blog.fidocure.com/fidocure-blog/pancreatic-cancer-in-dogs) Pancreatic cancer, though rare, is a serious condition in dogs, with two of the most common forms being insulinoma and pancreatic adenocarcinoma. These tumors can be life-threatening, but early detection and specialized care, including emerging treatments like targeted therapies, offer new hope for affected dogs. [Read More](https://blog.fidocure.com/fidocure-blog/pancreatic-cancer-in-dogs) ![](https://blog.fidocure.com/hubfs/Blog_AnalSacCarcinoma.png) ### [What to Know About Anal Sac Carcinoma](https://blog.fidocure.com/fidocure-blog/what-to-know-about-anal-sac-carcinoma) Anal sac carcinoma is a highly aggressive cancer that develops in the small glandular structures on either side of a dog's anus. These sacs produce a strong-smelling substance that dogs use as a territorial scent marker, among other reasons. Normally, this substance is released during defecation or when a dog is nervous or excited. However, in some cases, these anal sacs can develop cancerous tumors. [Read More](https://blog.fidocure.com/fidocure-blog/what-to-know-about-anal-sac-carcinoma) ![](https://blog.fidocure.com/hubfs/Blog_Database.png) ### [FidoCure Leads Canine Cancer Research with the World’s Largest Canine Cancer Database](https://blog.fidocure.com/fidocure-blog/fidocure-leads-canine-cancer-research-with-the-worlds-largest-canine-cancer-database) At FidoCure, we're committed to transforming cancer care for dogs through precision medicine. Our journey began with a mission to address a critical gap in canine cancer research and treatment. Prior to 2019, the field of canine cancer genomics lagged significantly behind its human counterpart. With only 2,000 canine tumor samples sequenced worldwide (compared to 20,000 human samples), the potential for precision medicine in veterinary oncology remained largely untapped. [Read More](https://blog.fidocure.com/fidocure-blog/fidocure-leads-canine-cancer-research-with-the-worlds-largest-canine-cancer-database) ![](https://blog.fidocure.com/hubfs/Blog_SoftTissueSarcoma%20(2).png) ### [A Guide to Soft Tissue Sarcoma in Dogs](https://blog.fidocure.com/fidocure-blog/a-guide-to-soft-tissue-sarcoma-in-dogs) Soft tissue sarcomas are one of the most common cancers affecting our canine companions. These tumors develop from a variety of soft tissue cells throughout the body, forming masses that pet owners often discover while petting their dogs. Soft tissue sarcomas can appear anywhere on the body but are frequently found on the limbs, trunk, head, and neck. This broad category of tumors includes various subtypes, each originating from different cell types such as muscle, fat, or nerve tissue. [Read More](https://blog.fidocure.com/fidocure-blog/a-guide-to-soft-tissue-sarcoma-in-dogs) ![](https://blog.fidocure.com/hubfs/Blog_HumanCancerDrugs.png) ### [Do Human Cancer Drugs Work on Dogs With Cancer?](https://blog.fidocure.com/fidocure-blog/do-human-cancer-drugs-work-on-dogs-with-cancer) At FidoCure, we're pioneering a revolutionary approach to treating canine cancer by bringing the power of precision medicine from human oncology to veterinary care. If your beloved dog has been diagnosed with cancer, you may have been told that the treatment options are limited. However, thanks to groundbreaking research and innovative technologies, there's new hope in the form of precision cancer drugs originally developed for humans. [Read More](https://blog.fidocure.com/fidocure-blog/do-human-cancer-drugs-work-on-dogs-with-cancer) ![](https://blog.fidocure.com/hubfs/Blog_HC.png) ### [Hepatocellular Carcinoma in Dogs: Understanding This Common Liver Cancer](https://blog.fidocure.com/fidocure-blog/hepatocellular-carcinoma-in-dogs-understanding-this-common-liver-cancer) Hepatocellular carcinoma (HCC) is the most common primary liver cancer in dogs. It can present as a single mass, multiple nodules, or diffuse spread throughout the liver, which increases the risk of metastasis. The main treatment options are surgical removal, metronomic chemotherapy, and/or Palladia. The prognosis is generally good for the single, massive form after surgery, but consulting a veterinary oncologist is recommended for all cases. [Read More](https://blog.fidocure.com/fidocure-blog/hepatocellular-carcinoma-in-dogs-understanding-this-common-liver-cancer) ![](https://blog.fidocure.com/hubfs/Blog_Pet%20Insurance.png) ### [How Pet Insurance Can Ease the Financial Burden of Cancer Treatment](https://blog.fidocure.com/fidocure-blog/how-pet-insurance-can-ease-the-financial-burden-of-cancer-treatment) When our beloved pets are diagnosed with cancer, it can be an emotionally and financially challenging time. As veterinary oncology advances, new and innovative cancer treatments are becoming available for our furry family members. However, these cutting-edge therapies can come with a significant price tag. [Read More](https://blog.fidocure.com/fidocure-blog/how-pet-insurance-can-ease-the-financial-burden-of-cancer-treatment) [1](https://blog.fidocure.com/fidocure-blog/author/fidocure) [2](https://blog.fidocure.com/fidocure-blog/author/fidocure/page/2) [3](https://blog.fidocure.com/fidocure-blog/author/fidocure/page/3) [4](https://blog.fidocure.com/fidocure-blog/author/fidocure/page/4) [5](https://blog.fidocure.com/fidocure-blog/author/fidocure/page/5) ![fc_portal_logo_bw](https://blog.fidocure.com/hubfs/fc_portal_logo_bw.svg) - [How it Works](https://fidocure.com/how-it-works/) - [FAQ](https://fidocure.com/faq/) - [Contact Us](https://fidocurestg.wpengine.com/contact-us/) - [For Vets](https://fidocure.com/for-veterinarians/) - [About Us](https://fidocure.com/about-us/) - [Terms of Service](https://fidocure.com/terms-of-service/) - [Blog](https://blog.fidocure.com/fidocure-blog) - [Careers](https://fidocure.com/careers/) - [Privacy Policy](https://fidocure.com/privacy-policy/) - - - - **FidoCure® is an advanced cancer-care service for dogs, developed by One Health Company**. DISCLAIMER: All patients are enrolled in FidoCure® by a veterinarian with a valid veterinarian-client-patient relationship (VCPR). We use best efforts to inform the veterinarian on available targeted therapy options for patients. FidoCure® does not prescribe therapy. The targeted therapies that veterinarians may prescribe and order from compounding pharmacies, after receiving genetic test results from FidoCure®, may constitute extra-label uses of those drugs. FidoCure® makes no claims that every patient will have genetic test results that lead to targeted therapy options. FidoCure® makes no claims or guarantees about the effectiveness of the diagnostic and targeted therapy selected by the veterinarian for an individual patient. Like most cancer care approaches, the services provided by FidoCure® are not a guarantee of a cure. FidoCure® is not a pharmacy and does not supply drugs directly. By ordering any medication via one of our pharmacy partners, you agree that the pharmacy, not FidoCure®, is solely responsible and liable for any and all issues relating to the preparation, dispensation and fulfillment of the medication. The lifetime offer is subject to the commercially reasonable availability of any medication(s) and/or active pharmaceutical ingredient(s) necessary for the selected therapy.  © Copyright 2018-2026 One Health Company, All rights reserved